MedPath

Ipratropium Bromide and Albuterol Sulfate

Ipratropium Bromide and Albuterol Sulfate

Approved
Approval ID

001e3b1c-b7c1-44aa-b812-e78dbf4f3069

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 27, 2017

Manufacturers
FDA

Medical Supply Distribution, Llc.

DUNS: 080470358

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ipratropium Bromide and Albuterol Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71152-201
Application NumberANDA076749
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ipratropium Bromide and Albuterol Sulfate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 22, 2017
FDA Product Classification

INGREDIENTS (5)

IPRATROPIUM BROMIDEActive
Quantity: 0.5 mg in 3 mL
Code: J697UZ2A9J
Classification: ACTIR
ALBUTEROL SULFATEActive
Quantity: 3 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ipratropium Bromide and Albuterol Sulfate - FDA Drug Approval Details